Document Format Files Seq Description Document Type Size 1 FORM S-3 ASR d874808ds3asr.htm S-3ASR 543111 2 EX-4.6 d874808dex46.htm EX-4.6 427097 3 EX-5.1 d874808dex51.htm EX-5.1 31139 4 EX-5.2 d874808dex52.htm EX-5.2 39661 5 EX-5.3 d874808dex53.htm ... SEC, 1 week ago
WARNER CHILCOTT LTD - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Except for the historical information contained herein, the following discussion contains forward-looking statements that are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from ...Pharmacy Choice, 1 week ago ACTAVIS PLC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Pharmacy Choice, 1 week ago
Winter 2014 Case Name: . , Nos. 2014-1439, 2014-1441, 2014-1444, 2014-1445, 2014-1446, 2014 U.S. App. LEXIS 21946 (Fed. Cir. Nov. 18, 2014) (Circuit Judges Lourie, Reyna and Taranto presiding; Opinion by Lourie, J.) (appeal from D. Del., Stark, ...JD Supra, 1 week ago
(SmarTrend(R) Spotlight via COMTEX News Network) -- SmarTrend identified an Uptrend for Warner Chilcott (NASDAQ:WCRX) on January 17th, 2013 at $13.53. In approximately 23 months, Warner Chilcott has returned 69.54% as of today's recent price of ...PredictWallStreet, 2 months ago
Actavis : Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 2014; Non-GAAP EPS Increases 23% to $3.91; Increases 2015 Standalone...
Actavis Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 2014; Non-GAAP EPS Increases 23% to $3.91 ; Increases 2015 Standalone Forecast By a News Reporter-Staff News Editor at Biotech Week -- Actavis plc (NYSE: ACT) reported ...4 Traders, 1 day ago Actavis Tops Views, Announces Name Change To Allergan Investor's Business Daily, 1 week ago Actavis plans name change to Allergan Drugmaker Actavis is planning to change its name as it draws closer to finishing another big deal, the $66 billion purchase of Botox maker Allergan that it announced last fall Mail.com, 6 days ago Actavis Changing Name to Allergan Wall Street Journal UK, 1 week ago
Vitamin D trials with almost a hundred thousand people are ongoing, with results starting to come in at the end of 2017. And until those results help fill the gaps in our knowledge of vitamin D , doctors should err on the side of caution and avoid ...MedPage Today, 2 days ago
The Treasury Department's crackdown on tax inversions last year has slowed but not stopped the movement of U.S. headquarters abroad as American businesses try to reduce tax bills and foreign firms seek to grow. Indeed, with U.S. companies now ...Yahoo! Finance, 3 days ago Tax System Gives Edge To Foreign Buys Of U.S. Firms Investor's Business Daily, 3 days ago
What it means to be 'big pharma' in a $980 billion industry (Part 4 of 10) ( Continued from Part 3 ) What are patents? A patent is an exclusive right granted for an invention. Patent protection means the invention cannot be commercially made, ...Yahoo! Finance, 3 days ago Hedge fund exec aims new legal weapon at Big Pharma's 'evergreened' patents FiercePharma, 1 month ago
BOSTON, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a clinical late stage biopharmaceutical company developing and commercializing novel tetracycline based antibiotics to treat serious infections where resistance ...BioSpace, 3 days ago Paratek Pharmaceuticals to Present at the Cowen Healthcare Conference MoneyShow.com, 4 days ago Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 Trial of Sarecycline Market Pulse Navigator, 1 month ago Paratek Pharmaceuticals, Inc. To Receive $4 Million Payment From Actavis With Initiation Of Phase 3 Trial Of Sarecycline BioSpace, 1 month ago
You may know me best for my recommendations and predictions for gold, energy and other natural resources. You probably know that supply and demand drive commodity prices. But what's driving this supply and demand? In many cases, it's ...Uncommon Wisdom Daily, 4 days ago
on your WebpageAdd Widget >Get your members hooked!